Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1989 Apr;42(4):422–426. doi: 10.1136/jcp.42.4.422

Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.

D W Rogers 1, J G Treleaven 1, J T Kemshead 1, J Pritchard 1
PMCID: PMC1141916  PMID: 2654192

Abstract

One hundred and sixty six bone marrow aspirates from children with abdominal neuroblastoma were independently examined for the presence of neuroblastoma cells by conventional haematological staining techniques and by indirect immunofluorescence using one or more of five monoclonal antibodies. Results using the two methods were evaluated by comparison with the results of bone marrow, bone and lymph node biopsy specimens taken at the same time, and in the light of the child's clinical course. One antibody, UJ13A, was found to have 98.5% specificity and 85.7% sensitivity, compared with sensitivities for conventional staining of 50% for aspirate alone and of aspirate or trephine biopsy specimen of 71.4%. The remaining antibodies UJ127/11, UJ223/8, UJ181/4 and UJ167/11, with specificities in the range 94-99%, were found to have sensitivities in the range 47-61%, lower than the sensitivity of conventionally stained aspirate or trephine biopsy specimen. Routine immunofluorescence staining with monoclonal antibody UJ13A should increase the sensitivity of detection of metastatic neuroblastoma.

Full text

PDF
424

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan P. M., Garson J. A., Harper E. I., Asser U., Coakham H. B., Brownell B., Kemshead J. T. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer. 1983 May 15;31(5):591–598. doi: 10.1002/ijc.2910310510. [DOI] [PubMed] [Google Scholar]
  2. Evans A. E., D'Angio G. J., Randolph J. A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer. 1971 Feb;27(2):374–378. doi: 10.1002/1097-0142(197102)27:2<374::aid-cncr2820270221>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  3. Favrot M. C., Frappaz D., Maritaz O., Philip I., Fontaniere B., Gentilhomme O., Bailly C., Zucker J. M., Gentet J. C., Kemshead J. Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow. Br J Cancer. 1986 Oct;54(4):637–641. doi: 10.1038/bjc.1986.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Franklin I. M., Pritchard J. Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies. J Clin Pathol. 1983 Nov;36(11):1215–1218. doi: 10.1136/jcp.36.11.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Garson J. A., van den Berghe J. A., Kemshead J. T. High-resolution in situ hybridization technique using biotinylated NMYC oncogene probe reveals periodic structure of HSRs in human neuroblastoma. Cytogenet Cell Genet. 1987;45(1):10–15. doi: 10.1159/000132417. [DOI] [PubMed] [Google Scholar]
  6. Joshi S. S., Kessinger A., Mann S. L., Stevenson M., Weisenburger D. D., Vaughan W. P., Armitage J. O., Sharp J. G. Detection of malignant cells in histologically normal bone marrow using culture techniques. Bone Marrow Transplant. 1987 Feb;1(3):303–310. [PubMed] [Google Scholar]
  7. Kemshead J. T., Goldman A., Fritschy J., Malpas J. S., Pritchard J. Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders. Lancet. 1983 Jan 1;1(8314-5):12–15. doi: 10.1016/s0140-6736(83)91559-3. [DOI] [PubMed] [Google Scholar]
  8. Oppedal B. R., Brandtzaeg P., Kemshead J. T. Immunohistochemical performance testing of monoclonal antibodies to neuroblastoma cells on normal adrenals, spinal and sympathetic ganglia, and neural crest tumours. Histopathology. 1987 Apr;11(4):351–362. doi: 10.1111/j.1365-2559.1987.tb02640.x. [DOI] [PubMed] [Google Scholar]
  9. Shafford E. A., Rogers D. W., Pritchard J. Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26. J Clin Oncol. 1984 Jul;2(7):742–747. doi: 10.1200/JCO.1984.2.7.742. [DOI] [PubMed] [Google Scholar]
  10. Tsokos M., Linnoila R. I., Chandra R. S., Triche T. J. Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round-cell tumors in children. Hum Pathol. 1984 Jun;15(6):575–584. doi: 10.1016/s0046-8177(84)80012-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES